Articles
Media
Publications
Conferences
CME/CE
Resources
Subscribe

Spotlight -

ZEISS Clinical Cases|

Heidelberg Engineering: Enhancing the Patient Journey

Mohammad Rafieetary, OD, FAAO

Articles by Mohammad Rafieetary, OD, FAAO

Sun rays stretch over the horizon as a sun rises or sets against a blue sky. Image credit: ©Pavlo Vakhrushev – stock.adobe.com

Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditions

BySheryl Stevenson,Anat Loewenstein, MD,Rishi P. Singh, MD,Martin Friedlander, MD, PhD,Mohammad Rafieetary, OD, FAAO

March 10th 2025

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

Latest Updated Articles

Trending on Ophthalmology Times Europe

AAO 2025: Home OCT provides a granular look at retinal pathologies

Sydnexis SYD-101 receives US FDA Complete Response Letter for paediatric myopia treatment

© 2025 MJH Life Sciences^®

All rights reserved.